Quantcast

Latest Immunosuppressants Stories

2013-10-17 23:19:38

Reportbuyer.com just published a new market research report: Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth. London (PRWEB) October 17, 2013 Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth Summary GBI Research, the leading business intelligence provider, has released its latest research, “Multiple Sclerosis...

2013-10-16 23:31:55

Neurological Wellness Center physicians encourage persons with mild to moderate Alzheimer’s disease to participate. Participants will be given weekly injections plus nutritional supplements that may suppress inflammatory processes associated with Alzheimer’s disease. (PRWEB) October 16, 2013 Many people receiving this treatment report a clearing of brain fog within minutes of receiving this injection. Pre-treatment and post-treatment cognitive function testing is utilized to document...

2013-10-14 23:21:18

Reportbuyer.com just published a new market research report: PharmaPoint: Psoriasis - UK Drug Forecast and Market Analysis to 2022. London (PRWEB) October 14, 2013 Summary GlobalData has released its new Country report, “PharmaPoint: Psoriasis - UK Drug Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective,...

2013-10-02 23:33:35

Pharmaceutical research companies are now investigating or developing 81 Alzheimer’s drugs.* A blockbuster treatment for moderate to severe Alzheimer’s is still more than ten years away according to Rolando Hernandez neurosurgeon for Neurological Wellness Center. (PRWEB) October 02, 2013 Pharmaceutical research has banked heavily on the beta amyloid hypothesis. The recent failures of bapineuzumab and solanezumab in phase III clinical trials has forced researchers to question weather...

2013-10-01 23:03:17

In-demand research report “Treating Refractory Hematological Malignancies - Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A” drawn up by MP Advisors has been recently published by Market Publishers Ltd. London,UK (PRWEB) October 01, 2013 Targeting unmet needs in treating hematological malignances through the development of innovative drugs has witnessed considerable achievements recently. Over the past 10 years, proteasome inhibitor Velcade (Bortezomib)...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related